# Franklin Financial Services Corp: financial statements, quarterly

FRAF · Nasdaq · CIK 723646 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fraf.md) · [Financials](/companies/fraf/financials.md) · [Filings](/companies/fraf/filings.md) · [Insiders](/companies/fraf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fraf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [6.4](/filings/0000723646-23-000071.md) | [7.6 d](/filings/0000723646-24-000019.md) | [10.3](/filings/0000723646-24-000042.md) | [10.5](/filings/0000723646-24-000054.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.8](/filings/0000723646-24-000071.md) | [0.6 d](/filings/0000723646-25-000020.md) | [0.6](/filings/0000723646-25-000047.md) | [0.6](/filings/0000723646-25-000062.md) | [0.9](/filings/0000723646-25-000080.md) | [0.1 d](/filings/0000723646-26-000016.md) | [0.9](/filings/0000723646-26-000055.md) | [1.4](/filings/0000723646-26-000074.md) | [1.3](/filings/0000723646-25-000080.md) | [1.4 d](/filings/0000723646-26-000016.md) | [1.7](/filings/0000723646-26-000055.md) | [1.6](/filings/0000723646-26-000074.md) |
| Net income | $m | [3.9](/filings/0000723646-24-000071.md) | [3.5 d](/filings/0000723646-25-000020.md) | [3.4](/filings/0000723646-25-000047.md) | [3.0](/filings/0000723646-25-000062.md) | [4.2](/filings/0000723646-25-000080.md) | [0.5 d](/filings/0000723646-26-000016.md) | [3.9](/filings/0000723646-26-000055.md) | [5.9](/filings/0000723646-26-000074.md) | [5.4](/filings/0000723646-25-000080.md) | [6.0 d](/filings/0000723646-26-000016.md) | [6.6](/filings/0000723646-26-000055.md) | [6.6](/filings/0000723646-26-000074.md) |
| Diluted EPS | $ per share | [0.88](/filings/0000723646-24-000071.md) | not reported | [0.77](/filings/0000723646-25-000047.md) | [0.66](/filings/0000723646-25-000062.md) | [0.95](/filings/0000723646-25-000080.md) | not reported | [0.88](/filings/0000723646-26-000055.md) | [1.32](/filings/0000723646-26-000074.md) | [1.19](/filings/0000723646-25-000080.md) | not reported | [1.48](/filings/0000723646-26-000055.md) | [1.47](/filings/0000723646-26-000074.md) |
| Basic EPS | $ per share | [0.89](/filings/0000723646-24-000071.md) | not reported | [0.77](/filings/0000723646-25-000047.md) | [0.67](/filings/0000723646-25-000062.md) | [0.96](/filings/0000723646-25-000080.md) | not reported | [0.88](/filings/0000723646-26-000055.md) | [1.32](/filings/0000723646-26-000074.md) | [1.20](/filings/0000723646-25-000080.md) | not reported | [1.48](/filings/0000723646-26-000055.md) | [1.47](/filings/0000723646-26-000074.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [74.0](/filings/0000723646-23-000071.md) | [23.1](/filings/0000723646-25-000020.md) | [183](/filings/0000723646-24-000042.md) | [180](/filings/0000723646-24-000054.md) | [236](/filings/0000723646-24-000071.md) | [204](/filings/0000723646-26-000016.md) | [225](/filings/0000723646-25-000047.md) | [208](/filings/0000723646-25-000062.md) | [188](/filings/0000723646-25-000080.md) | [128](/filings/0000723646-26-000074.md) | [211](/filings/0000723646-26-000055.md) | [195](/filings/0000723646-26-000074.md) |
| Total assets | $m | [1,828](/filings/0000723646-23-000071.md) | [1,836](/filings/0000723646-25-000020.md) | [2,012](/filings/0000723646-25-000047.md) | [2,039](/filings/0000723646-24-000054.md) | [2,151](/filings/0000723646-25-000080.md) | [2,198](/filings/0000723646-26-000016.md) | [2,257](/filings/0000723646-26-000055.md) | [2,287](/filings/0000723646-26-000074.md) | [2,297](/filings/0000723646-25-000080.md) | [2,239](/filings/0000723646-26-000074.md) | [2,298](/filings/0000723646-26-000055.md) | [2,335](/filings/0000723646-26-000074.md) |
| Total liabilities | $m | [1,713](/filings/0000723646-23-000071.md) | [1,704](/filings/0000723646-25-000020.md) | [1,877](/filings/0000723646-24-000042.md) | [1,902](/filings/0000723646-24-000054.md) | [2,001](/filings/0000723646-24-000071.md) | [2,053](/filings/0000723646-26-000016.md) | [2,106](/filings/0000723646-25-000047.md) | [2,129](/filings/0000723646-25-000062.md) | [2,131](/filings/0000723646-25-000080.md) | [2,064](/filings/0000723646-26-000074.md) | [2,119](/filings/0000723646-26-000055.md) | [2,151](/filings/0000723646-26-000074.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [115](/filings/0000723646-24-000071.md) | [132](/filings/0000723646-26-000016.md) | [134](/filings/0000723646-25-000062.md) | [137](/filings/0000723646-25-000080.md) | [150](/filings/0000723646-25-000080.md) | [145](/filings/0000723646-26-000074.md) | [151](/filings/0000723646-26-000074.md) | [157](/filings/0000723646-26-000074.md) | [166](/filings/0000723646-25-000080.md) | [175](/filings/0000723646-26-000074.md) | [179](/filings/0000723646-26-000074.md) | [184](/filings/0000723646-26-000074.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.3 d](/filings/0000723646-24-000071.md) | [5.9 d](/filings/0000723646-25-000020.md) | [7.3](/filings/0000723646-25-000047.md) | [2.4 d](/filings/0000723646-25-000062.md) | [7.8 d](/filings/0000723646-25-000080.md) | [4.2 d](/filings/0000723646-26-000016.md) | [8.8](/filings/0000723646-26-000055.md) | [5.1 d](/filings/0000723646-26-000074.md) | [8.3 d](/filings/0000723646-25-000080.md) | [3.2 d](/filings/0000723646-26-000016.md) | [24.1](/filings/0000723646-26-000055.md) | [6.7 d](/filings/0000723646-26-000074.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.4 d](/filings/0000723646-24-000071.md) | [1.4 d](/filings/0000723646-25-000020.md) | [1.4](/filings/0000723646-25-000047.md) | [1.4 d](/filings/0000723646-25-000062.md) | [1.4 d](/filings/0000723646-25-000080.md) | [1.4 d](/filings/0000723646-26-000016.md) | [1.4](/filings/0000723646-26-000055.md) | [1.5 d](/filings/0000723646-26-000074.md) | [1.5 d](/filings/0000723646-25-000080.md) | [1.5 d](/filings/0000723646-26-000016.md) | [1.5](/filings/0000723646-26-000055.md) | [1.5 d](/filings/0000723646-26-000074.md) |
| Share repurchases | $m | [0.0 d](/filings/0000723646-24-000071.md) | [0.0 d](/filings/0000723646-25-000020.md) | [0.0](/filings/0000723646-25-000047.md) | [0.4 d](/filings/0000723646-25-000062.md) | [0.2 d](/filings/0000723646-25-000080.md) | [0.2 d](/filings/0000723646-26-000016.md) | [0.1](/filings/0000723646-26-000055.md) | [0.3 d](/filings/0000723646-26-000074.md) | [0.3 d](/filings/0000723646-25-000080.md) | [0.4 d](/filings/0000723646-26-000016.md) | [0.4](/filings/0000723646-26-000055.md) | [0.4 d](/filings/0000723646-26-000074.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,424](/filings/0000723646-23-000071.md) | [4,417](/filings/0000723646-24-000042.md) | [4,388](/filings/0000723646-24-000054.md) | [4,369](/filings/0000723646-24-000071.md) | [4,386](/filings/0000723646-25-000047.md) | [4,562](/filings/0000723646-25-000062.md) | [4,423](/filings/0000723646-25-000080.md) | [4,451](/filings/0000723646-26-000055.md) | [4,471](/filings/0000723646-26-000074.md) | [4,498](/filings/0000723646-25-000080.md) | [4,486](/filings/0000723646-26-000055.md) | [4,503](/filings/0000723646-26-000074.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,499,582 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0000723646-26-000074.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.